| DMBIO Y DM Bio Limited
79302421 16 Dec 2020 | on 19 Dec 2023 | Pharmaceutical preparations for the treatment of the central nervous s... Class 005 Class 005 Pharmaceutical Products The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey. Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer | | | DMBIO Y DM Bio Limited
79148927 19 Dec 2013 | on 19 Dec 2023 | Pharmaceutical preparations for the treatment of the central nervous s... Class 005 Class 005 Pharmaceutical Products The mark consists of the wording "DMBIO Y". The letter "D" is in blue, the letter "M" is in red, and the letters "BIO" are in grey. The letter "Y" is to the upper right of "DMBIO" in the colors red, blue and grey. Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer | |